Genolution Inc. (KOSDAQ:225220)

Market Cap	51.05B
Revenue (ttm)	11.33B
Net Income (ttm)	-4.72B
Shares Out	19.19M
EPS (ttm)	-517.84
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,904
Average Volume	53,796
Open	2,735.00
Previous Close	2,680.00
Day's Range	2,605.00 - 2,735.00
52-Week Range	1,980.00 - 5,140.00
Beta	0.29
RSI	47.11
Earnings Date	Nov 14, 2024

About Genolution

Genolution Inc. manufactures and sells IVD products in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and dsRNA research for the prevention of breeding and extermination. The company offers Nextractor, an automatic extraction system for isolation of DNA or RNA from various samples; and FFPE, whole blood, buccal swab, RV, TB/NTM, STD, HPV, HBV, and CMV/EBV extraction kits, as well as rice, plant, and cell extraction kits. It also provides siRNA/shRNA sy...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2006
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 225220

Financial Performance

In 2022, Genolution's revenue was 38.08 billion, a decrease of -47.71% compared to the previous year's 72.83 billion. Earnings were 14.60 billion, a decrease of -57.55%.